Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$6.29 From HK$8.45, Keeps at Buy
Analysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)
MicroPort Scientific: Modest Growth and Narrowing Losses Prompt Hold Rating Despite Long-Term Caution
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)
Analysts Offer Insights on Healthcare Companies: Calliditas Therapeutics (CALT), AK Medical Holdings Ltd. (HK:1789) and Consun Pharmaceutical Group Ltd. (Frankfurt: DE:C1P)
Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF)
MicroPort Scientific (MCRPF) Gets a Hold From Nomura
Nomura Adjusts MicroPort Scientific's Price Target to HK$7.19 From HK$17.59, Keeps at Neutral
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy From Jefferies
Jefferies Reaffirms Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)
Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$14.79 From HK$15.90, Keeps at Buy
Jefferies Adjusts Yunnan Energy New Material's Price Target to 196 Yuan From 184 Yuan, Keeps at Buy
UBS Adjusts Yunnan Energy New Material's Price Target to 376 Yuan From 386.50 Yuan, Keeps at Buy
Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$12.55 From HK$11.87, Keeps at Buy
UBS Adjusts New Horizon Health's Price Target to HK$51 From HK$47, Keeps at Buy